Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
about
Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attackCGRP may play a causative role in migraineRole of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized ratsInvolvement of nitric oxide in the modulation of dural arterial blood flow in the rat.Pharmacology and potential mechanisms of action of rizatriptan.Calcitonin gene-related peptide: A molecular link between obesity and migraine?The extracranial vascular theory of migraine--a great story confirmed by the facts.Diencephalic and brainstem mechanisms in migraine.Physiology of meningeal innervation: aspects and consequences of chemosensitivity of meningeal nociceptors.Modelling headache and migraine and its pharmacological manipulationThe antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.Primary headaches: a convergence hypothesis.The discovery of a new drug class for the acute treatment of migraine.Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.Effects of a selective 5-HT(1B/1D) receptor agonist on spinal and trigeminal reflexes in the anaesthetized rabbit.Update on animal models of migraine.Neurobiology of chronic tension-type headache.Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I.The influence of gender and sex steroids on craniofacial nociception.New migraine and pain research.The blood-brain barrier in migraine treatment.Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice.Allodynia in migraine: frequent random association or unavoidable consequence?Animal models of headache: from bedside to bench and back to bedside.The extracranial vascular theory of migraine: an artificial controversy.Chemical mediators of migraine: preclinical and clinical observations.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular SystemPathophysiology of Migraine: A Disorder of Sensory Processing.CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat.Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres.Glyceryl trinitrate may trigger endogenous nitric oxide production in patients with chronic tension-type headache.Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo.CGRP infusion in unanesthetized rats increases expression of c-Fos in the nucleus tractus solitarius and caudal ventrolateral medulla, but not in the trigeminal nucleus caudalis.Calcitonin gene-related peptide and migraine with aura: A systematic review.Lack of correlation between vasodilatation and pharmacologically induced immediate headache in healthy subjects
P2860
Q28174159-D6875CEE-3093-4FC3-A537-4554473EE2F4Q28216666-05CD20AC-8793-4EBB-9AD5-5F6C00ED2982Q28343904-CB917C50-DF55-439F-ACA1-42F562944162Q30853246-FFD7EAA3-C6E7-4589-BC62-0AF787E4A588Q34082299-98819C6F-5947-4667-99CE-679576AC6391Q34162706-62A7CC44-D6AC-4B3D-9965-BEC90B0B1624Q34166916-CEB9F4A9-094E-48A8-96D3-CCE6B31923B7Q34217686-E5DAEA26-3E86-47DA-A751-0CEC0A07C3BEQ34218301-A45F86CA-347B-44E7-A0BC-1866E8B25DA5Q34407137-B8419E3C-2D36-4442-B283-32894CD7B2F9Q34529520-EE42CCF8-F908-4C8D-8DAF-C47EE46D0A6FQ34570686-F43F91B9-3020-487D-BDCD-FB5FDA1D52C0Q34617817-B53ED509-2514-4760-82B7-416E0AC751D9Q34720188-629D21E2-5CFC-43FC-BEFB-B512BB530B6DQ35042847-3542B94F-B9AE-41A8-8A11-EB40B091B543Q35280862-7AB694B1-AD57-4C2B-86B9-C01D7AC34FDDQ35685806-DBA04776-59AD-4582-A243-041D7FB2F471Q36367877-63FABAA5-DB07-49C0-A5B1-63B2ECA2254DQ36735667-5C680302-9A2A-45D2-A50B-5F5E7604279EQ36787453-078CCFA9-CEB2-4E25-8BC7-55182E550E57Q37252452-2E39CDD4-D5EF-4EE1-A239-F6C1EF3837BFQ37363843-F3210C76-32B2-4962-94A6-5C816EF19AADQ37409505-50FFAE37-6EA9-4F61-BA29-2C693C17FDF0Q37699421-A05BBC4B-7EA4-48BA-840C-9E1D10CF916FQ37826098-7D0CAB43-509A-49FF-94D2-0ABAB2AAF94FQ37883455-DABBF517-4151-44D4-B545-150105676175Q38129436-8185A0B1-8F13-4F07-AAC6-E14EC59E8FF4Q38708391-CDDDB230-2185-4142-AFBD-BEDEA6692045Q39127073-B31E9058-D8CC-4697-A5D4-D61B5B021313Q41139207-D429E2F6-DCCA-43B7-B8E8-67D509E82781Q42151308-5024D7DB-31D7-4523-BDD1-8D50BD59B18BQ44073647-86830F59-9674-4656-93EE-395106D1F3A5Q45105205-DEA10FA2-38C6-4D1F-A7D9-4B6F83F60B6DQ46580205-C9386A87-C6DC-4DE9-A2CE-77FA86E19271Q47861956-F0E2F2CE-2C04-4236-8A31-82A3F6743783Q48366274-F7549E35-1DB0-48C0-B685-149C32E02A35Q57024089-9CE01CB7-E4CB-488B-B409-F8344A12E599
P2860
Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@en
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@nl
type
label
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@en
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@nl
prefLabel
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@en
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@nl
P2093
P2860
P356
P1476
Dural vasodilation causes a se ...... locked by a 5-HT1B/1D agonist.
@en
P2093
D J Williamson
M J Cumberbatch
R J Hargreaves
P2860
P304
P356
10.1038/SJ.BJP.0702444
P407
P577
1999-03-01T00:00:00Z